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Background: The disorders in metabolism of energy substances are usually related to some diseases, such as
obesity, diabetes and cancer, etc. However, the genetic background for these disorders has not been well
understood. In this study, we explored the genetic risk differences among human populations in metabolism
(catabolism and biosynthesis) of energy substances, including lipids, carbohydrates and amino acids.
Results: Two genotype datasets (Hapmap and 1000 Genome) were used for this study. The genetic risks of protein
functional changing variants (PFCVs) on genes involved in lipid, carbohydrate and amino acid metabolism were
calculated using two genetic risk indices: the total number of PFCVs (Num) and the total possibly harmful score of
PFCVs (R). Observations in these two genotype datasets consistently showed that Africans had lower genetic risk in
lipid metabolism (both catabolic and biosynthetic processes) compared to Europeans. However this relationship
was not observed in carbohydrate and amino acid metabolism.
Conclusions: Our results suggested that Africans had higher efficiency of utilizing lipids as energy substances than
Europeans. In other words, lipids might be more preferred as energy substances in Africans than in Europeans.Introduction
Many complex diseases are closely related to the disor-
ders in energy substances metabolism. Among three
main energy substances (carbohydrates, lipids, and
amino acids), lipids are often majorly studied because
observed abnormalities in their metabolism can induce
complex diseases, such as obesity, diabetes, and cancer,
etc. [1-3]. The genetic background of lipid metabolism
might be at the core of understanding these complex
diseases.
It is usually easier to understand genetic differences at
population level than at individual level. It has been well
reported that the prevalence of many complex diseases,
such as obesity, coronary heart diseases, and hyperten-
sion, etc. are race related and the genetic risks associated
with these diseases might be different among different
populations [4-8]. For example, the prevalence of hyper-* Correspondence: yunxin.fu@uth.tmc.edu
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reproduction in any medium, provided the ortension among African-Americans is 1.5–2-fold higher
than European-Americans [9].
Many kinds of genetic robustness, such as duplicate
genes and biologically complicated networks, exist in
human genomes [5,10-13], which explain why loss of
functions of one or more genes have little phenotypic ef-
fect. However, the accumulation of protein functional
changing variants (PFCVs) might reduce or even destroy
this robustness [5,10,13]. The vast majority of complex
diseases have many genes involved, to which each gene
only contributes a very small amount of effect [14].
Therefore, more PFCVs on genes involved in energy me-
tabolisms might lead to higher genetic risk developing
complex diseases at population level [5].
In our previous study with Hapmap data [5], we re-
ported that Africans had significantly fewer PFCVs in
whole catabolic process than non-Africans. In this study,
with the use of two genotype datasets (Hapmap and
1000 Genome), we further investigated the genetic risks
(R and Num) in metabolic processes of three main ener-
gy substances (carbohydrates, lipids and amino acids)
among human populations. Results showed that R and. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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were significantly smaller in Africans than in Europeans.
However, for catabolic or biosynthetic process of carbohy-
drates and amino acids, R and Num were either larger or
not smaller in Africans compared to Europeans. Based on
these observations, we hypothesized that Africans had
higher efficiency of utilizing lipids as energy substances




Hapmap genotype, downloaded from HapMap project,
was sampled from 11 human groups (Hapmap Public
Release #3 on May 28, 2010, http://hapmap.ncbi.nlm.
nih.gov/). The detailed information about these human
groups are listed in Table 1. In brief, Human population
= {African, East Asian, European, GIH, MEX}, in whichTable 1 Overview of Genotype datasets used in this study
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African Yoruba in Ibadan,
Nigeria
YRI 5African = {ASW, LWK, MKK, YRI}, East Asian = {CHB,
CHD, JPT}, European = {CEU, TSI}, and GIH and MEX
are two independent groups. The genotype data in some
human groups (ASW, CEU, MXL, MKK and YRI) con-
tained family trios data which could bias the results.
Therefore the offspring for each trio of these groups
were excluded from further analyses. Table 1 shows the
final data set used for this study.
1000 Genome low-coverage genotype data (released in
July, 2010), downloaded from 1000 Genome project
(ftp://ftp-trace.ncbi.nih.gov/1000genomes/ftp/pilot_data/
release/2010_07/low_coverage/snps/), was sampled from
CEU (European-American), CHB and JPT(East Asian),
and YRI (African) (Table 1).
Genotype data preparation and genetic risk estimation
The preparation for the studied genotype data, the me-
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in our previous study [5]. Here we only focus briefly on
the points specifically for this study.
The missense mutations of genes that were involved in
metabolism of carbohydrates, lipids and amino acids were
mainly considered in this study. The harmful impacts of
many missense mutations over the genes were estimated
using Polyphen-2 [15] collected in dbNSFP [16]. For sim-
plicity, the alleles with minor allele frequency (MAF) were
called mutations throughout this article.
The genes involved in the metabolic processes of carbo-
hydrates, lipids, and amino acids were downloaded from
Gene Ontology (GO) (http://www.geneontology.org). The
name, symbol, and chromosome location of these selected
genes are shown in details in Additional file 1: Table S1-S6
of supporting information. The total number of genes for
each GO term is shown in Table 2. PFCVs with missense
mutations on these genes were downloaded from NCBI
dbSNP database (ftp://ftp.ncbi.nih.gov/snp/). The harmful
probability for each PFCV estimated by Polyphen-2 was
downloaded from http://genetics.bwh.harvard.edu/pph2/
dbsearch.shtml. For a false positive rate of 20%, the true
positive prediction rate in PolyPhen-2 trained on HumDiv
dataset is 92%, so the HumDiv-trained score for each mu-
tation is referenced [15].
Two indices, R and Num of PFCVs, were used to as-
sess the genetic risk in metabolic processes of carbohy-
drates, lipids and amino acids. The methods used to
calculate R and Num were described in details in our
previous study [5].
Permutation test
In this study, we used permutation to reduce the back-
ground risk level when assessing the actual genetic risks.
Total 18161 genes in human genome were used for the
assessment and they were downloaded from http://www.
geneontology.org. Two types of permutation tests were
conducted in this study. 1. Gene-based permutation. Of
these 18161 genes, the given number of genes (the num-
ber of genes involved in carbohydrate, lipid or amino
acid metabolism (catabolism and biosynthesis), Table 2)
were re-sampled randomly up to 2000 times, followedTable 2 The number of genes in energy expenditure and stor
Energy materia








(translation)by the calculations of R and Num for these genes. 2.
PFCV-based permutation. The number of harmful
PFCVs on a given set of genes (the set of genes involved
in the carbohydrate, lipid or amino acid metabolism,
Table 2) were counted and recorded. The same number
of PFCVs was re-sampled randomly from total PFCVs of
18161 human genes up to 2000 times, followed by the
calculations of R and Num on these re-sampled PFCVs.
Because the results from these two tests were very simi-
lar [5], in this article we only showed and discussed the
results obtained by using the gene-based permutation
test. The results of these permutation tests were used as
an estimation to the background risk when analyzing
data.
For example, the total number of genes involved in
lipid catabolic process for Africans and Europeans was
218 (Table 2), therefore 218 genes were re-sampled ran-
domly each time from 18161 human genes and R and
Num were calculated on these genes as background risk
level of R and Num for Africans and Europeans. At each
round of re-sampling, we calculated the mean of R (or
Num) and the mean difference R’ (R’ = mean RAfrican –
mean REuropan). Total 2000 of R’ were obtained for each
population for 2000 re-sampling processes and the dis-
tribution of R’ was close to normal (Additional file 2:
Figure S1-S12). The actual observed mean difference
(R’lipid_catabolism) for lipid catabolic process was also cal-
culated. P-Value was approximately equal to the number
of re-sampled with R’< R’lipid_catabolism divided by 2000.
Statistical methods
The unpaired two-tailed Student’s test, the F test
(ANOVA, Analysis of Variance) and permutation tests
were performed to assess the genetic risks among three
subpopulations (Africans, Europeans and Asians) and 11
human groups (ASW, LWK, MKK, YRI, CHB, CHD,
JPT, CEU, TSI, GIH and MEX).
Results
Overview of the studied data
In this study, two genotype datasets, Hapmap and 1000
Genome, were used for the analyses. A few characteris-age processes in Gene ontology
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had larger number of population groups (three sub-
populations with 11 human groups) while 1000 Genome
only had three subpopulations with four human groups.
Second, sample sizes were similar between Hapmap
(58 ≤ size ≤ 156) and 1000 Genome (59 for YRI and 60
for CEU and CHB and JPT). Third, 1000 Genome had
the most PFCVs, including total number of PFCVs and
total number of PFCVs with missense mutation (Table 1).
These features indicated that some differences existed
between Hapmap and 1000 Genome, regarding the
number of human groups, the density of PFCVs, and the
sample size. As a result, we explained the outcomes for
each dataset separately although we used the same me-
thods to analyze these data.
Hapmap
Our results showed that in carbohydrate metabolism,
most of the background R (on genes randomly sampled
from human genomes using permutation test) was big-
ger than the observed R (on genes involved in metabo-
lism of energy substances) (Figures 1, 2 and 3). It was
intriguing that the observed R in carbohydrate catabolicFigure 1 The observed R (grey bar) and the background (white bar) R
dataset in carbohydrate catabolic and biosynthetic processes (mean±
Results for carbohydrate catabolic process. B: Results for carbohydrate biosprocess was significantly bigger than the background R
(P << 0.01, Figure 1A). This result suggested that carbo-
hydrate catabolic process might specially harbor more
genetic mutations than expected (average on back-
ground). We also implemented the comparison of the
observed R in catabolic and biosynthetic processes of
carbohydrate among subpopulations (African, European
and Asian) and among 11 human groups. The results
showed no significant differences among subpopulations
(P = 0.1903, F test, Table 3) in carbohydrate catabolic
process, suggesting that the genetic risk R in carbohy-
drate catabolic process might be very similar among
Africans, Europeans and Asians. However, among 11 hu-
man groups in carbohydrate catabolic process, the ob-
served R in GIH was significantly bigger than all other
human groups (P < 0.01, t-test, Figure 1A). In carbohy-
drate biosynthetic process, the observed R was signifi-
cantly different among subpopulations (P < 2.2 × 10-16,
F test, Table 3), and the R for all African groups was sig-
nificantly bigger than non-African groups. (P < 0.01,
t-test, all pairs, Figure 1B), suggesting that the genetic
risk R in carbohydrate biosynthetic process in Africans
might be the largest among human groups.on protein functional changing variants (PFCVs) for Hapmap
SD). The background Rs were obtained using permutation test. A:
ynthetic process.
Figure 2 The observed R (grey bar) and the background R (white bar) on protein functional changing variants (PFCVs) for Hapmap
dataset in lipid catabolic and biosynthetic processes (mean±SD). The background Rs were obtained using permutation test. A: Results for
lipid catabolic process. B: Results for lipid biosynthetic process.
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cantly smaller than the background R for each human
group (P << 0.01, t-test, all pairs, Figure 2A), while the
observed R in lipid biosynthetic process was also signifi-
cantly smaller than the background R among most hu-
man groups with two exceptions (CEU and TSI) whose
observed R were significantly bigger ( P <0.05, t-test,
Figure 2B). In lipid catabolic process, the observed R in
Africans was significantly smaller than all non-African
groups (P < 0.05, t-test, all pairs, Figure 2A) with the fact
that LWK of Africans held the smallest R (Figure 2A). In
lipid biosynthetic process, the observed R in Africans
was significantly smaller than Europeans (P < 0.01,
Figure 2B). As far as the relationship of the observed R
between Africans (ASW, LWK, MKK, YRI) and Asians
(CHB, CHD, JPT), several different observations were
obtained. First, the observed R in ASW and LWK was
significantly smaller than CHB or smaller than CHD and
JPT with no significance. Second, the observed R in YRI
was significantly smaller than all Asian groups (CHB,
CHD, and JPT). Third, MKK was the only group whose
observed R was not significantly different from all Asian
groups (Figure 2B). These observations suggested thatthe genetic risk R for lipid biosynthetic process in Africans
might be smaller than all European groups and most of
Asian groups.
The observed R in amino acid metabolic processes
was consistently smaller than the background R. Espe-
cially, the ratio of R (the observed to the background) in
the amino acid biosynthetic process was the smallest
among all studied metabolic processes (Figures 1, 2 and
3), which suggested that, compared to the metabolism of
carbohydrates and lipids, the biosynthesis of amino acids
were more conservative and might harbor fewer mutations.
In amino acid catabolic process, the observed R in most
African groups were significantly smaller than Europeans
and Asians (P < 0.01) with the exception of MKK whose R
was significantly bigger than others (P < 0.01, Figure 3A).
In amino acid biosynthetic process, the observed R
in Africans was significantly bigger than non-Africans
(P < 0.05), especially R in LWK, MKK and YRI were much
bigger than other human groups (P < 0.01, Figure 3B). The
observed R of Asians in amino acid biosynthetic process
was the smallest among all studied human groups.
Additionally, we also implemented the comparison of
the genetic risks (R and Num) between males and
Figure 3 The observed R (grey bar) and the background R (white bar) on protein functional changing variants (PFCVs) for Hapmap
dataset in amino acid catabolic and biosynthetic processes (mean±SD). The background Rs were obtained using permutation test. A:
Results for amino acid catabolic process. B: Results for amino acid biosynthetic process.
Table 3 Analysis of Variance for Observations (ANOVA) of R estimated on genes in carbohydrate catabolic and
biosynthetic process based on Hapmap data a
Metabolic Process Item Df. Sum Sq. Mean Sq. F value Pr(>F)
Catabolic process
gender 1 0 0.00333 0.0019 0.9654
subpopulation 2 5.87 2.93506 1.6619 0.1903
group 6 12.49 2.08155 1.1786 0.3152
gender x subpopulation 2 1.24 0.62057 0.3514 0.7038
gender x group 6 8.39 1.39836 0.7918 0.5764
Residuals 1050 1854.45 1.76614
Biosynthetic process
gender 1 0.01 0.007 0.0061 0.93769
subpopulation 2 103.55 51.777 45.0708 < 2.2 x 10-16 ***
group 6 19.33 3.221 2.8038 0.01037 *
gender x subpopulation 2 1.25 0.624 0.5432 0.58106
gender x group 6 4.19 0.698 0.6075 0.72451
Residuals 1050 1206.24 1.149
* The difference is greatly significant (P<0.05).
*** The difference is greatly significant (P<<0.01).
a The data in African (ASW, LWK, MKK and YRI), East Asian (CHB, CHD and JPT) and European (CEU and TSI) are used for this analysis.
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there were no significant difference between males and
females (P > 0.05, t- test, Table 3).
The above results for observed R were obtained without
using the adjustment for background risk level. How-
ever, even with the consideration of background risk
level, we still got the similar results (Additional file 2:
Figure S13-S15).
1000 Genome (low-coverage, pilot data)
1000 Genome provides more variants than Hapmap
(Table 1). Therefore here we used 1000 Genome data to
replicate the results obtained by using Hapmap data.
Without considering background risk level, mean R’
or mean Num’ observed between Africans-Europeans or
Africans-Asians (mean RAfrican – mean REuropean or
mean NumAfrican – mean NumEuropean) was observed to
be bigger than 0 in 1000 Genome (Additional file 2:
Figure S4-S15). This observation was different from the
results observed using Hapmap data (see above) which
might be resulted from the difference of total PFCVs
between Hapmap and 1000 Genome (Table 1). After
adjusting the background risk level using permutation
test, we observed that R and Num in both lipid catabolic
and lipid biosynthetic processes were significantly
smaller in Africans than in Europeans (P < 0.05, permu-
tation test, Table 4, Additional file 2: Figure S5 and S8).
However, for carbohydrate and amino acid metabolisms,
the significant difference of R or Num between Africans
and Europeans was not observed in either catabolic orTable 4 Statistic results of permutation test for the difference





















a R’ is the difference of mean genetic risk in carbohydrate, lipid and amino acid metab
for the test for the difference between African and European, which means the probab
being smaller than the difference observed in a given metabolic process.
* means P-Value<0.05.biosynthetic process (P > 0.05, Table 4, Additional file 2:
Figure S4-S15). We also observed that R and Num in lipid
catabolic process were smaller in Africans than in Asians
with no significance (P = 0.099 for R; P = 0.0125 for
Num). but this relationship was not observed in lipid bio-
synthetic process between Africans and Asians (P = 0.797
for R; P = 0.865 for Num) (Table 4, Additional file 2:
Figure S11 and S14). The above observations suggested
that the genetic risks (R or Num) in lipid catabolic and
lipid biosynthetic processes were smaller in Africans than
in Europeans, while in metabolisms of carbohydrates and
amino acids, this relationship was not held.
We hypothesized that in order to respond to high-energy
food environment, the smaller genetic risks among
Africans in lipid metabolism might be translated to
higher efficience of utilizing lipids as energy substances
metabolism compared to Europeans.
This hypothesis could be tested with a simple experi-
mental design. Triglycerides (TGs), the main energy sub-
stances in lipids, are usually biosynthesized in liver and
are transported in blood as part of lipoprotein particles
to the end of body for energy expenditure or energy
storage [3,17]. With smaller genetic risks (R and Num)
among Africans in lipid biosynthetic process, the effi-
ciency of TGs biosynthesis in liver cells might be higher
compared to Europeans [5,10]. Thus based on our hy-
pothesis, the first clinical prediction should be that TGs
level in arm arterial serum among Africans should be
higher compared to Europeans . It was reported clini-
cally that TGs level in arm venous serum was lower inof mean R in carbohydrate, lipid and amino acid
e consideration of background level in 1000 Genome
1000 Genome data
African Vs. European African Vs. Asian
R'African-European P-value R'African-Asian P-value
-0.2307 0.0535 2.947 0.4925
0.5753 0.072 1.93 0.099
0.8928 0.3275 0.545 0.111
3.642 0.718 3.066 0.324
1.798 0.0385* 11.25 0.797
4.236 0.213 9.857 0.6485
0.6644 0.12 8.45 0.5425
-0.865 0.03* 1.24 0.0115*
3.516 0.483 1.34 0.0975
9.85 0.735 7.43 0.2535
4.857 0.048* 30.45 0.865
6.0 0.0725 21.93 0.3775
olism between African and European (or Asian); P-value is P(R’<R’African-European)
ility of the difference (R’) between African and European in permutation test
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between arterial and venous serum (TGarterial-venous) was
usually larger than 0 [19], which suggested that it might
not be appropriate to infer TGs in arterial serum using
TGs in venous serum. TGarterial-venous represented the
net consumption of TGs in lipids expenditure and sto-
rage. Our second clinical prediction should be that
TGarterial-venous would be higher in Africans than in
Europeans. Therefore, the data of TGs in arterial and
venous serum obtained at the same time can be used to
examine the predictions of our hypothesis.
Discussion
It has been well known that background genetic risks
are usually different among different human populations
such that one population could have more genetic vari-
ants than others [5,13,20]. Our previous [5] and current
study observed that Africans had more background gen-
etic risk than Europeans. Some studyies reported that
Africans had smaller proportion of homozygous muta-
tions but bigger proportion of heterozygous compared
to Europeans [20], suggesting that the excessive muta-
tions in background for Africans might be shelved under
the recessive model. Generally speaking, the difference
of background genetic risk among populations might
not result in possible racial difference for fitness or some
other phenotypes. But the difference of genetic variant
distribution in some body systems (for example lipid
metabolism) might result in racial difference in some
phenotypes (for example obesity, diabetes and cancer).
To access racial difference of genetic variants in these
systems among human populations, we had to remove
the background noise through permutation test to make
sure whether the racial differences of R or Num we ob-
served in lipid metabolism were attributed to the back-
ground level or not.
If our hypothesis (Africans on average having higher
efficiency of utilizing lipids during energy expenditure
and storage) hold true, then lipids might be the more
preferred energy substances for Africans compared to
Europeans. As lipids are higher energy biomolecules
compared to carbohydrates and proteins (the energy
level for carbohydrates or proteins is ~4 calories per
gram, while for lipids it is ~9 calories per gram), the
preference of lipids as energy substances during energy
expenditure might result in more economic energy gen-
eration in Africans compared to non-Africans. Clinically,
Hunter et al. (2000) reported that when doing the same
activity, African-descendant women consumed lower
volumes of metabolically active masses [21]. This obser-
vation corresponded with our hypothesis of the prefer-
ence of lipids as energy substances in Africans. Higher
efficiency in energy expenditure along with lower con-
sumption of body masses might contribute jointly tohigher prevalence of obesity in Africans in high-energy
food environment [4]. Meanwhile, more preference of
lipids in energy storage might provoke the accumulation
of fats in body.
In this study, we observed significantly fewer PFCVs in
lipid metabolism among Africans than Europeans. Be-
cause most of PFCVs (or missense mutations) are detri-
mental, fewer PFCVs on genes in lipid metabolism
might increase the efficiency of utilizing lipids as energy
substances in Africans. This observation might exten-
sively explain the differences of blood lipid level and its
related phenotypes (or diseases) among human groups
[8,9]. Of course, a lot of further studies are needed to
elucidate the relationship between the PFCVs on the
genes and the phenotypes (or diseases) associated with
lipid metabolism. Of these studies, the study design we
proposed in this paper to test the hypothesis could be
the first step towards that goal.
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